Prescient Therapeutics Limited (ASX:PTX)
Australia
· Delayed Price · Currency is AUD 0.0460
-0.0010 (-2.13%)
Apr 30, 2025, 4:10 PM AEST
Prescient Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 6.39 | 10.49 | 5.9 | 12.26 | 16.1 | 7.36 | Upgrade
|
| Short-Term Investments | 2.02 | 4.02 | 16.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 8.41 | 14.51 | 21.92 | 12.28 | 16.12 | 7.38 | Upgrade
|
| Cash Growth | -54.41% | -33.78% | 78.41% | -23.79% | 118.48% | -23.63% | Upgrade
|
| Accounts Receivable | 5.19 | 3.92 | 2.58 | 1.72 | 1.24 | 1.06 | Upgrade
|
| Receivables | 5.19 | 3.92 | 2.58 | 1.72 | 1.24 | 1.06 | Upgrade
|
| Prepaid Expenses | 1.34 | 0.31 | 0.25 | 0.24 | 0.24 | 0.27 | Upgrade
|
| Total Current Assets | 14.93 | 18.74 | 24.74 | 14.25 | 17.6 | 8.71 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 1.65 | 1.65 | 3.37 | 3.37 | 3.37 | 3.37 | Upgrade
|
| Total Assets | 16.58 | 20.39 | 28.11 | 17.62 | 20.97 | 12.07 | Upgrade
|
| Accounts Payable | 0.66 | 1.72 | 1.78 | 0.51 | 0.23 | 0.48 | Upgrade
|
| Accrued Expenses | 0.24 | 0.22 | 0.2 | 0.12 | 0.07 | 0.05 | Upgrade
|
| Short-Term Debt | 0.03 | 0.33 | - | - | 0.17 | 0.16 | Upgrade
|
| Other Current Liabilities | - | 0.05 | 0.05 | 0.18 | 0.04 | 0.18 | Upgrade
|
| Total Current Liabilities | 0.93 | 2.32 | 2.03 | 0.81 | 0.51 | 0.86 | Upgrade
|
| Total Liabilities | 0.93 | 2.33 | 2.03 | 0.86 | 0.54 | 0.88 | Upgrade
|
| Common Stock | 93.27 | 93.27 | 93.25 | 77.26 | 76.67 | 63.93 | Upgrade
|
| Retained Earnings | -79.31 | -77.4 | -69.31 | -62.45 | -57.51 | -53.46 | Upgrade
|
| Comprehensive Income & Other | 1.68 | 2.19 | 2.14 | 1.95 | 1.26 | 0.72 | Upgrade
|
| Shareholders' Equity | 15.65 | 18.07 | 26.08 | 16.76 | 20.43 | 11.19 | Upgrade
|
| Total Liabilities & Equity | 16.58 | 20.39 | 28.11 | 17.62 | 20.97 | 12.07 | Upgrade
|
| Total Debt | 0.03 | 0.33 | - | - | 0.17 | 0.16 | Upgrade
|
| Net Cash (Debt) | 8.37 | 14.18 | 21.92 | 12.28 | 15.95 | 7.22 | Upgrade
|
| Net Cash Growth | -54.59% | -35.28% | 78.41% | -22.99% | 120.93% | -25.25% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 805.32 | 805.32 | 805.27 | 654.32 | 641.05 | 394.26 | Upgrade
|
| Total Common Shares Outstanding | 805.32 | 805.32 | 805.27 | 654.32 | 641.05 | 394.26 | Upgrade
|
| Working Capital | 13.99 | 16.42 | 22.71 | 13.44 | 17.08 | 7.84 | Upgrade
|
| Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Tangible Book Value | 14 | 16.42 | 22.71 | 13.4 | 17.06 | 7.82 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.